Virlaza™ Inhibits Sars-COV-2-induced Inflammatory Response of Bronchial Epithelial Cells and Pulmonary Fibroblast
Maysa Alves Rodrigues Brandao-Rangel, Dobroslav Melamed, Anamei Silva-Reis, Boris Brill, Lucas dos Santos Zamarioli, Carlos Rocha Oliveira, View ORCID ProfileRodolfo P Vieira
doi: https://doi.org/10.1101/2021.07.17.21260123
Maysa Alves Rodrigues Brandao-Rangel
1Federal University of São Paulo (UNIFESP), Laboratory of Pulmonary and Execise Immunology, Rua Talim 330, São José dos Campos – SP, Brazil, 12231-280
Dobroslav Melamed
2Libipharm, Research and Development Department, Ben Gurion 70, Rechovot, Israel, 7639461
Anamei Silva-Reis
1Federal University of São Paulo (UNIFESP), Laboratory of Pulmonary and Execise Immunology, Rua Talim 330, São José dos Campos – SP, Brazil, 12231-280
Boris Brill
2Libipharm, Research and Development Department, Ben Gurion 70, Rechovot, Israel, 7639461
Lucas dos Santos Zamarioli
3Federal University of São Paulo, Department of Pharmacology, Rua Três de Maio 100, São Paulo – SP, Brazil, 04044-020
Carlos Rocha Oliveira
4Anhembi Morumbi University, School of Medicine, Avenida Deputado Benedito Matarazzo 6070, São José dos Campos – SP, Brazil, 12230-002
5Federal University of São Paulo (UNIFESP), Post-graduation Program in Biomedical Engineering, Rua Talim 330, São José dos Campos – SP, Brazil, 12231-280
Rodolfo P Vieira
1Federal University of São Paulo (UNIFESP), Laboratory of Pulmonary and Execise Immunology, Rua Talim 330, São José dos Campos – SP, Brazil, 12231-280
6Universidade Brasil, Post-graduation Program in Bioengineering, Rua Carolina Fonseca 235, São Paulo – SP, Brazil, 08230-030
7Brazilian Institute of Teaching and Research in Pulmonary and Exercise Immunology (IBEPIPE), Rua Pedro Ernesto 240, São José dos Campos – SP, Brazil, 12245-520
Article usage
Posted July 22, 2021.
Virlaza™ Inhibits Sars-COV-2-induced Inflammatory Response of Bronchial Epithelial Cells and Pulmonary Fibroblast
Maysa Alves Rodrigues Brandao-Rangel, Dobroslav Melamed, Anamei Silva-Reis, Boris Brill, Lucas dos Santos Zamarioli, Carlos Rocha Oliveira, Rodolfo P Vieira
medRxiv 2021.07.17.21260123; doi: https://doi.org/10.1101/2021.07.17.21260123
Virlaza™ Inhibits Sars-COV-2-induced Inflammatory Response of Bronchial Epithelial Cells and Pulmonary Fibroblast
Maysa Alves Rodrigues Brandao-Rangel, Dobroslav Melamed, Anamei Silva-Reis, Boris Brill, Lucas dos Santos Zamarioli, Carlos Rocha Oliveira, Rodolfo P Vieira
medRxiv 2021.07.17.21260123; doi: https://doi.org/10.1101/2021.07.17.21260123
Subject Area
Subject Areas
- Addiction Medicine (383)
- Allergy and Immunology (699)
- Anesthesia (192)
- Cardiovascular Medicine (2853)
- Dermatology (244)
- Emergency Medicine (430)
- Epidemiology (12560)
- Forensic Medicine (10)
- Gastroenterology (806)
- Genetic and Genomic Medicine (4434)
- Geriatric Medicine (401)
- Health Economics (716)
- Health Informatics (2850)
- Health Policy (1048)
- Hematology (375)
- HIV/AIDS (893)
- Medical Education (413)
- Medical Ethics (114)
- Nephrology (462)
- Neurology (4194)
- Nursing (222)
- Nutrition (617)
- Oncology (2204)
- Ophthalmology (624)
- Orthopedics (254)
- Otolaryngology (318)
- Pain Medicine (268)
- Palliative Medicine (82)
- Pathology (486)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6782)
- Radiology and Imaging (1490)
- Respiratory Medicine (900)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (201)
- Urology (174)